Loading open roles.
Loading open roles.
ProteinQure is building the world’s leading AI platform for peptide drug design, focused on extracellular targets. Our lead program, PQ203 for TOP1-resistant triple-negative breast cancer—a disease with no approved treatment options—has just entered Phase I trials in the US and Canada. Our platform has been validated in collaborations with four of the top 25 pharmaceutical companies and leverages
Roles are read from ProteinQure’s Greenhouse every hour and disappear here as soon as they close there.